Study of families with TP53 gene changes in Li-Fraumeni syndrome
Part of Cancer, Genetic & congenital, Hormones & metabolism clinical trials.
This study is looking at how people in families with certain TP53 gene changes (including Li-Fraumeni syndrome) develop health problems over time. It may help doctors better understand risk and improve care for affected families.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a known TP53 gene change (pathogenic or likely pathogenic) in blood or saliva, or a qualifying reason for enrollment decided by the study doctor
- You are a blood relative of someone with a TP53 change (or a healthy comparison person in that family)
- You may qualify if you meet “Li-Fraumeni syndrome” family-pattern criteria (Classic or Chompret), even if no TP53 gene change was found
- You may also qualify if the TP53 change is related to other TP53-related conditions (like ACE, CHIP, or mosaicism), even if it’s not Li-Fraumeni
- You (or the person’s family) must be willing to sign the study consent forms, or have a suitable healthcare proxy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects and stores health information and biological samples from people who have a known TP53 change (Li-Fraumeni syndrome) and from close family members. The goal is to help researchers learn more about risks and future treatments for this genetic condition.
This study collects medical and genetic information to better understand how often cancer develops in people with Li-Fraumeni syndrome and related family risks. It may help families and doctors plan earlier awareness and follow-up over a person’s lifetime.
This trial compares standard genetic counseling with a more personalized approach for people considering or receiving TP53 genetic testing. It may help by seeing which counseling style better supports you before and after testing for a TP53 inherited change.
This is a research registry that collects information from people who have Li-Fraumeni or similar inherited cancer syndromes. It helps doctors better understand these conditions and improve future care.
This study screens individuals who may have a genetic condition that increases cancer risk. It looks for certain inherited syndromes, like Li-Fraumeni syndrome, RASopathies, or bone marrow failure syndromes, and helps determine if further genetic testing or cancer monitoring is needed.
This study looks at results from people who have already had TP53 gene testing through IEO’s genetics clinic. It helps doctors learn more about how this gene relates to cancer risk.
Hear when a new Li-Fraumeni Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.